Aluminum, in Vaccines, Also Cause Serious Health Conditions, Including Chronic Fatigue, Neurodegenerative Diseases, Macrophagic
- Aluminum adjuvants in vaccines have been linked to a range of health issues, including macrophagic myofasciitis (MMF), chronic fatigue syndrome, and neurodegenerative diseases.
- Studies reveal that aluminum particles can persist in the body for up to eight years, leading to chronic inflammation and immune system over-activity.
- The World Health Organization (WHO) acknowledges the long-term persistence of aluminum at injection sites but downplays the potential health risks.
- Research suggests that genetic and environmental factors may make some individuals more susceptible to the adverse effects of aluminum adjuvants.
In the world of vaccine science, aluminum adjuvants have long been the backbone of the science, enhancing the immune response to antigens and ensuring the effectiveness of many vaccines. However, recent studies and clinical observations have cast a shadow over this widely used compound, revealing a darker side to its role in human health. The French medical community, in particular, has been at the forefront of investigating the adverse reactions linked to aluminum adjuvants, uncovering a complex web of health issues that challenge the conventional wisdom of vaccine safety.